Skip to content
Dynamic Betting Zone

The Zimbabwean Government Declines ‘One-Sided’ US Health Aid Agreement Due to Information Fears

Health funding image
The proposed American funding was intended for initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has turned down a major American health deal valued at $367m (£272m) spanning five years due to the United States' request for confidential biological samples.

This move came to light following a government memo from December was leaked, indicating that President Emmerson Mnangagwa deemed the deal was "skewed".

A government spokesman has since explained that the United States was demanding access to genetic material for scientific study and commercial gain but was unwilling to share the benefits from any future treatments.

"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for more dialogue to find a deal acceptable to both sides so the nation's vital HIV treatment initiative can proceed.

Wider Implications

This rejection follows a comparable situation in neighbouring Kenya, where a high court blocked a related deal with the US following legal challenges were raised about the security of Kenyans' health data.

Since resuming office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump argued its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance transparency and accountability.

According to reports, Sixteen African countries have so far agreed to similar health pacts, representing over $18.3bn of fresh investment.

Specifics of the Declined Agreement

This assistance for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this partnership would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Our nation was requested to provide its biological resources and data indefinitely, without any equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.

"In essence, our country would supply the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our population should a new pandemic arise."

National Interest and Global Health

He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining systems previously set up via the international health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.

"This mechanism is intended to guarantee that when a country provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to create them."

The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.

"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the sovereignty and interests of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks must proceed considering much of the country's HIV programmes relied on foreign aid.

"If technical issues exist, including those involving information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it said.

The situation underscores the continuing debate between receiving much-needed international aid and safeguarding a country's data in an increasingly data-driven world.

DG
Written by

Dustin Gregory

A seasoned sports analyst with over a decade of experience in betting strategies and statistical modeling, specializing in football and basketball markets.

Dynamic Betting Zone

Type to search articles.